Company: IBM United Kingdom Limited
Category: Supply Chain Management
Published: September 2004
Short-term cost and productivity measures are not enough to meet the fundamental challenges the pharmaceutical industry (Pharma) now faces. On the contrary, any company that wants to fend off the risks, and exploit the opportunities, that are currently emerging will need to submit its supply chain to a radical overhaul. The quality of a company’s manufacturing and distribution can either impede its progress in getting products to market or accelerate that process and become a means of creating value.
Rating: + 2
Business Technology Optimisation | May 2013 | White Paper
Mobile Device Management | March 2013 | White Paper
Mobile Device Management | March 2013 | Video
Consumerisation | March 2013 | White Paper
Application Security | February 2013 | White Paper
© Incisive Media Investments Limited 2013, Published by Incisive Financial Publishing Limited, Haymarket House, 28-29 Haymarket, London SW1Y 4RX, are companies registered in England and Wales with company registration numbers 04252091 & 04252093.